Certain Options of Recursion Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2021. These Options will be under lockup for 181 days starting from 15-APR-2021 to 13-OCT-2021. Details: The executive officers and substantially all of issuer's stockholders (such persons, the “lock-up parties”), have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of 180 days after the date of this prospectus without the prior written consent of Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC.